Pfizer Receives Approvable Letter For Maraviroc. Investigation Continues.
Pfizer just announced that the U.S. Food and Drug Administration (FDA) issued an approvable letter for maraviroc, as a therapy for HIV patients. Labeling is not yet finalized.
Pfizer did not comment on the ongoing investigation related to unapproved marketing allegations by a sales rep.
You can read that story here.